Lanean...
Biomarkers in phase I–II chemoprevention trials: lessons from the NCI experience
Early phase clinical trials are an essential component of chemopreventive drug development to identify signals of drug efficacy that can subsequently be explored definitively in phase III trials. Whereas phase I trials focus on safety and identification of optimal dose and schedule for cancer preven...
Gorde:
| Argitaratua izan da: | Ecancermedicalscience |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Cancer Intelligence
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4664504/ https://ncbi.nlm.nih.gov/pubmed/26635903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.599 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|